Skip to content
value.today

Macrogen, Inc.

038290.KQ
$153 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Macrogen, Inc. in brief

Macrogen, Inc. is a listed company in the Healthcare sector, based in South Korea. Its last known market value was $153 M (January 2024); there is no current figure. Its shares trade under the symbol 038290.KQ (South Korea).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

$0 M$45 M$89 M$134 M$178 M20232024

World rank over time

▲ up 283 places since 2022
2022-12-25: #19584#19,58420222023-07-30: #19083#19,08320232024-01-05: #19301#19,3012024

Rank in South Korea: #613 (Dec 2022) · #616 (Jul 2023) · #653 (Jan 2024)

Mutual funds holding Macrogen, Inc.#

8 funds hold shares worth $0 M. Since their previous reports 0 added shares and 6 sold, selling $0 M net.
Mutual funds holding Macrogen, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP37,889$0 M—<0.01%no changeJul 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP7,618$0 M—<0.01%−38%Jul 31, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP7,487$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP4,268$0 M—<0.01%−36%Jul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP1,886$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP1,285$0 M—<0.01%−71%Jul 31, 2026
🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP1,168$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP12$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 8 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

CompanyMarket capP/ENet marginRev. growth
Macrogen, Inc.🇰🇷$153 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Macrogen, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Macrogen, Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Macrogen, Inc.? Suggest a correction